Novartis researchers are learning how a novel approach to immunotherapy could help treat cancer.

Lutz Hegemann shares how lessons learned treating patients with leprosy influenced the way he thinks about the pharmaceutical business.

We’re working to bring the hope of advanced medicine to more patients.

Myriam Mendila describes how Novartis continued supporting cancer patients and healthcare professionals during the pandemic.

Researchers focus on reversing the scarring that’s common to liver diseases.